Stock Information
Insmed Inc (INSM)
Ticker Symbol: INSM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $31,848.13 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -6.4018
Revenue (TTM): $2.84 M
Dividend Yield: N/A%
ROE: -168.36%
Latest News
-
INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study
Tue, Mar 24, 2026 1:09 PM
-
Insmed eyes Arikayce label expansion on Phase IIIb lung disease success
Tue, Mar 24, 2026 12:30 PM
-
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday
Tue, Mar 24, 2026 9:40 AM
-
Stifel Maintains Buy on Insmed, Raises Price Target to $208
Tue, Mar 24, 2026 9:19 AM
-
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $177
Tue, Mar 24, 2026 9:06 AM
-
B of A Securities Maintains Buy on Insmed, Raises Price Target to $213
Tue, Mar 24, 2026 8:18 AM
-
A Look At Insmed (INSM) Valuation After Positive ENCORE Phase 3b ARIKAYCE Data
Tue, Mar 24, 2026 1:08 AM
-
Sector Update: Health Care Stocks Advance Late Afternoon
Mon, Mar 23, 2026 7:54 PM
-
US Equity Indexes Jump, Crude Oil Slides as Trump Offers 5-Day Reprieve to Iran Amid 'Productive' Talks
Mon, Mar 23, 2026 5:14 PM
-
Insmed ENCORE Phase 3 Trial Hits Primary Endpoint; ARIKAYCE Drives Strong MAC Culture Conversion Gains
Mon, Mar 23, 2026 4:21 PM
Key Financials
Financial data not available
